Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments.
The Transformational Research: Canada program funds transformative, novel, high-risk, high-reward translational research projects. Projects can be from $200,000 to $1,500,000.
Accepting applications on diet, physical activity, sleep and nutritional supplements, if these applications meet our other scope criteria.
Encouraging applications that bring in expertise, technologies or approaches in the following areas to advance the development of therapeutics and tools for neurodegenerative diseases of aging: artificial intelligence, big data, machine learning, data science, computer science, medicinal chemistry, biostatistics and engineering.
Encouraging applications at all funding levels from $200,000 to $1,500,000.
This option has been removed from the program details, however if this kind of funding is desired please contact the Institute: If the funded project has the potential for significant commercial success, in the grant agreement, the Institute may request, upon significant commercial success, repayment of grant funds to be used for further research funding.
Translational research using humans or human samples/data is in scope, except for clinical trials or clinical trial sub-studies which should be submitted to the Early-Phase Clinical Trials or Rapid Response programs.
The Institute has updated which tools are in scope. Please read our What We Fund webpage before applying to ensure your project is in scope.